Real-World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Wolfram,Samlowski

第一单位： Comprehensive Cancer Centers of Nevada and University of Nevada Las Vegas Kirkorian School of Medicine, Las Vegas, Nevada, USA.

作者： Wolfram,Samlowski ^[1] ; Nicholas J,Robert ^[2] ; Liwei,Chen ^[3] ; Brad,Schenkel ^[3] ; Catherine,Davis ^[4] ; Andriy,Moshyk ^[4] ; Srividya,Kotapati ^[4] ; Tayla,Poretta ^[4] ; Jeffrey S,Weber ^[4]

作者单位： Comprehensive Cancer Centers of Nevada and University of Nevada Las Vegas Kirkorian School of Medicine, Las Vegas, Nevada, USA. ^[1] University of Nevada School of Medicine, Reno, Nevada, USA. ^[2] McKesson Life Sciences, The Woodlands, Texas, USA. ^[3] Bristol Myers Squibb, Princeton, New Jersey, USA. ^[4] Perlmutter Cancer Center, NYU School of Medicine, New York, New York, USA. ^[5]

关键词 adjuvant therapy dosing interval flat dosing melanoma nivolumab real-world safety tolerability

主题词人类(Humans);黑色素瘤(Melanoma);综合疗法(Combined Modality Therapy);佐剂, 免疫(Adjuvants, Immunologic);回顾性研究(Retrospective Studies)

DOI 10.1002/cam4.5061

PMID 35880244

发布时间 2023-02-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Cancer medicine

2023年12卷3期

2378-2388页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Real-World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma.

Cancer medicine

相似文献

Cancer medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Real-World nivolumab dosing patterns and safety outcomes in patients receiving adjuvant therapy for melanoma.

Cancer medicine

相似文献

Cancer medicine

相关期刊

检索历史清除